Rituxan (rituximab) - Roche
bendamustine - Generic mfg.
sofosbuvir/velpatasvir - Generic mfg.
Persistent Hepatitis C Viremia Following Sofosbuvir/Velpatasvir During Bendamustine-Rituximab Therapy for Follicular Lymphoma. (PubMed, Clin Case Rep) - Sep 26, 2026 - "This is a case of a 67-year-old female with follicular lymphoma who developed hepatitis C viremia during chemotherapy and failed treatment with a 12-week course of sofosbuvir/velpatasvir. This highlights the possibility that chemotherapy may have contributed to failure to achieve sustained virologic response despite otherwise appropriate direct-acting antiviral therapy." 
Journal • Follicular Lymphoma • Hematological Malignancies • Hepatitis C • Infectious Disease • Inflammation • Lymphoma • Oncology
http://www.ncbi.nlm.nih.gov/pubmed/42787531
 
Chisom J Orakwue; Rade N Pejic
 
Sep 26, 2026
 
Prev Next